Please use this identifier to cite or link to this item:
|Title:||Genomics and IP: An Overview|
|Keywords:||Genomics;IP protection;ESTs;Microarrays;DNA sequencing|
|Abstract:||The field of genomics and systems biology promises to provide unconventional solutions to problems relating to healthcare and agriculture. The various biotechnologies centred on genomics are undeniably a dominant force in the world of economics and the stakes are enormous. The field of genomics and system biology is immensely cross-sectoral and flourishes the most when the knowledge from various domains are integrated. However, this very essence of genomics adds layers of complexities while segregating the contributions from various domains related to IPRs. The foremost technologies guiding the advancements in the field of genomics include genome-wide sequencing, high throughput expression profiling, bioinformatics and the resultant databases. The need to protect and capitalize innovation is sacrosanct to best business practices. At the same time, providing access to the benefits accruing from such innovations to public is of importance to the society at large. IPR regime attempts to meet these seemingly conflicting objectives of providing incentive to the innovators and yet acting as a disclosure mechanism for promoting a continuum in research and development. This dual reward-and-disclosure clause is beneficial to both the inventor and the end user. This article attempts to map the high throughput genomic technologies along with their attendant databases and analysis tools. Through this outline, the article makes an attempt to inform the extent of IP protection and issues emanating from the application of such technologies.|
|Appears in Collections:||JIPR Vol.12(1) [January 2007]|
Files in This Item:
|JIPR 12(1) (2007) 57-71.pdf||152.36 kB||Adobe PDF||View/Open|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.